Wearable CGM Growth: US $32.48 B by 2033 at 10.3% CAGR | Dexcom, Abbott, Senseonics
The global wearable continuous glucose monitoring devices market is projected to grow from US $12.20 billion in 2024 to US $32.48 billion by 2033, at a robust CAGR of 10.3%. Market leaders such as Dexcom, Abbott (Libre), Medtronic, Senseonics drive adoption with innovations in OTC CGMs, extended sensors, and AI-powered analytics.